3 completed, 1 terminated. 2 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 2 |
Follow Salome Kristensen: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Risk of Diabetes Mellitus in Patients With Giant Cell Arthritis and Polymyalgia Rheumatica. Giant Cell Arteritis, Polymyalgia Rheumatica | Completed | Salome Kristensen | 198 | 2023-08-01 | 2026-04-30 | |
| PROM Collected Via a WebApp Versus a Touch Screen Solution Among Patients With SLE PROM registration via the DANBIO WebApp and the outpatient touchscreen in a randomised order - Systemic Lupus Erythematosus | Not applicable | Completed | Salome Kristensen | 34 | 2020-07-15 | 2021-04-01 |
| COVID-19 Infection in Vulnerable Patients With Inflammatory Rheumatic Diseases COVID-19 infection - Rheumatoid Arthritis, Psoriatic Arthritis | Terminated | Salome Kristensen | 53 | 2020-04-23 | 2021-07-21 | |
| PROM Collected Via a Smartphone App Versus a Touch Screen Solution Among Patients With Inflammatory Arthritis PROM registration via the DANBIO App on a smartphone, PROM registration via the touch screen solution - Rheumatoid Arthritis, Psoriatic Arthritis | Not applicable | Completed | Salome Kristensen | 60 | 2019-04-24 | 2019-10-02 |
Arthritis, Psoriatic (2) · Arthritis, Rheumatoid (2) · Axial Spondyloarthritis (2) · Giant Cell Arteritis (2) · Lupus Erythematosus, Systemic (2) · Polymyalgia Rheumatica (1)
Denmark (4)
2018 (1)